Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

58.42
BATS BZX Real-Time Price
As of 1:04pm ET
 +0.72 / +1.25%
Today’s Change
36.44
Today|||52-Week Range
58.52
+45.32%
Year-to-Date
Haemonetics (HAE) at 52-Week High: What's Driving the Stock?
Nov 20 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Q2 Earnings Beat Estimates, EPS View Up
Nov 08 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Grows on Strong Plasma, Competition Rife
Nov 15 / Zacks.com - Paid Partner Content
Haemonetics (HAE) in Focus: Stock Moves 10% Higher
Nov 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close57.70
Today’s open58.14
Day’s range57.87 - 58.52
Volume2,170
Average volume (3 months)366,283
Market cap$3.0B
Dividend yield--
Data as of 1:04pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+53.21%
Earnings growth (this year)+11.19%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)-2.68%
P/E ratio835.6
Price/Sales2.36
Price/Book4.08

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.55+1.20%
MMSIMerit Medical System...+1.60+3.82%
INGNInogen Inc+0.60+0.49%
NXTMNxStage Medical Inc+0.44+1.70%
Data as of 1:06pm ET, 11/21/2017

Financials

Next reporting dateJanuary 29, 2018
EPS forecast (this quarter)$0.44
Annual revenue (last year)$886.1M
Annual profit (last year)-$26.3M
Net profit margin-2.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts